The estimated Net Worth of Ben Gil Price is at least $585 Mille dollars as of 29 January 2019. Dr Price owns over 15,000 units of NeuroBo Pharmaceuticals Inc stock worth over $56,250 and over the last 12 years he sold NRBO stock worth over $0. In addition, he makes $529,232 as CEO & Pres at NeuroBo Pharmaceuticals Inc.
Sign up
Dr D NRBO stock SEC Form 4 insiders trading
Dr has made over 4 trades of the NeuroBo Pharmaceuticals Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently he bought 15,000 units of NRBO stock worth $9,150 on 29 January 2019.
The largest trade he's ever made was buying 15,000 units of NeuroBo Pharmaceuticals Inc stock on 29 January 2019 worth over $9,150. On average, Dr trades about 1,885 units every 153 days since 2012. As of 29 January 2019 he still owns at least 15,000 units of NeuroBo Pharmaceuticals Inc stock.
You can see the complete history of Dr Price stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Dr. Ben Gil Price M.D. biography
Dr. Ben Gil Price M.D. is the CEO & Pres at NeuroBo Pharmaceuticals Inc.
What is the salary of Dr D?
As the CEO & Pres of NeuroBo Pharmaceuticals Inc, the total compensation of Dr D at NeuroBo Pharmaceuticals Inc is $529,232. There are no executives at NeuroBo Pharmaceuticals Inc getting paid more.
How old is Dr D?
Dr D is 65, he's been the CEO & Pres of NeuroBo Pharmaceuticals Inc since . There are 1 older and 10 younger executives at NeuroBo Pharmaceuticals Inc. The oldest executive at NeuroBo Pharmaceuticals Inc is Michael Salsbury, 70, who is the Independent Director.
What's Dr D's mailing address?
Ben's mailing address filed with the SEC is C/O NEUROBO PHARMACEUTICALS, INC., 200 BERKELEY STREET, OFFICE 19TH FLOOR, BOSTON, MA, 02116.
Insiders trading at NeuroBo Pharmaceuticals Inc
Over the last 5 years, insiders at NeuroBo Pharmaceuticals Inc have traded over $0 worth of NeuroBo Pharmaceuticals Inc stock and bought 2,544,530 units worth $7,964,379 . The most active insiders traders include St Co., Ltd Dong A, Tae Heum Jeong e Steven R. Ph.D. Gullans. On average, NeuroBo Pharmaceuticals Inc executives and independent directors trade stock every 0 days with the average trade being worth of $9,541,988. The most recent stock trade was executed by St Co., Ltd Dong A on 23 June 2024, trading 2,544,530 units of NRBO stock currently worth $7,964,379.
What does NeuroBo Pharmaceuticals Inc do?
neurobo pharmaceuticals, inc., a clinical-stage biotechnology company provides therapies for neurodegenerative and cardiometabolic diseases. its therapeutics programs include nb-01 for the treatment of painful diabetic neuropathy; nb-02 to treat cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of protein; and gemcabene, which is focused on developing and commercializing therapies for the treatment of dyslipidemia. neurobo pharmaceuticals, inc. was incorporated in 2017 and is headquartered in boston, massachusetts.
What does NeuroBo Pharmaceuticals Inc's logo look like?
Complete history of Dr Price stock trades at Sarepta Therapeutics Inc e NeuroBo Pharmaceuticals Inc
NeuroBo Pharmaceuticals Inc executives and stock owners
NeuroBo Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Dr. Ben Gil Price M.D.,
CEO & Pres -
Nicola Shannon,
Vice President - Clinical Operations -
Akash Bakshi,
Sr. VP & COO -
Michael Miller,
Investor Relations -
Douglas Swirsky,
Independent Director -
Michael Salsbury,
Independent Director -
Jeong Gyun Oh,
Independent Director -
Tae Heum Jeong,
Independent Director -
Jason Groves,
Independent Director -
Mark Versavel,
Chief Medical Officer -
jeong Gu Kang,
President, Chief Executive Officer, Interim Chief Financial Officer, Secretary, Treasurer and Director -
Na Yeon Kim,
Independent Chairman of the Board -
Frank Kondrad,
VP of Corp. & Bus. Devel. -
Dr. Matthew Bardin BCPS, Pharm.D.,
Sr. VP of Operations -
Dr. Nadja Mannowetz Ph.D.,
Sr. VP -
Dr. Andrew Bartynski Ph.D.,
Sr. VP -
Dr. Gil Price M.D.,
CEO, Pres & Chief Medical Officer -
Dr. Jeong Gu Kang Ph.D.,
Pres, CEO, Sec., Interim CFO, Treasurer & Director -
St Co., Ltd Dong A,
-
Mark A Glickman,
Director -
Akash Bakshi,
SVP and COO -
Steven R. Ph.D. Gullans,
Director -
James Patrick Tursi,
Director -
Ben Gil Price,
CEO and President -
D Gordon Strickland,
Director -
Richard Kang,
Director -
Inc.E&Healthcare Investment...,
-
Hyung Heon Kim,
CEO & President -
Marshall H Woodworth,
Chief Financial Officer